Cynata Therapeutics treats final patient in stem cell clinical trial – Proactive Investors Australia
Proactive Investors Australia |
Cynata Therapeutics treats final patient in stem cell clinical trial
Proactive Investors Australia Cynata’s vice president of product development Dr Kilian Kelly said: “Treating the final patient in the phase I trial of our novel CYP-001 stem cell therapy in GvHD represents a significant milestone and great achievement for Cynata. “In an analysis of … |
ITV News |
Charity urges shorter ‘contemplation window’ to boost stem cell transplants
ITV News People wait for more than a year to give blood or stem cells after making an initial decision to donate, a poll suggests. The Anthony Nolan charity said there is a 15-month “contemplation window” – from the moment people first consider donation to when … |
Futurity: Research News |
Embryonic stem cells form useful proto-nervous system
Futurity: Research News It’s possible to guide human embryonic stem cells to become the precursor tissue of the central nervous system, research demonstrates. The new study also reveals the important role of mechanical signals in the development of the human nervous system. A first look at the earliest decisions that shape a human embryoThe Rockefeller University Newswire Elusive master organizer of human embryo growth seen for the first …Science Magazine |